Skip to main content
Clinical Trials/ACTRN12612000264886
ACTRN12612000264886
Recruiting
Phase 4

Assessment of Mucosal Immunity to Polioviruses after Supplemental Poliovirus Vaccines in Different Groups of Healthy Children in Pakistan: A Randomized Controlled Trial; Aga Khan University, Karachi

WHO0 sites1,485 target enrollmentMarch 6, 2012

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
poliomyelitis
Sponsor
WHO
Enrollment
1485
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 6, 2012
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
WHO

Eligibility Criteria

Inclusion Criteria

  • Healthy children aged 6\-11 months, 5\-6 years or 10\-11\-years, that reside within a relatively short and easily accessible distance (\<30 km) to the study sites, and do not plan to travel away during entire the study period

Exclusion Criteria

  • Children with known thrombocytopenia or bleeding disorders; children acutely ill or with signs of acute infection (e.g. fever \> 101 F) at the time of enrolment; residence \>30 km from study site; or families expecting to be absent during the 60\-day study period. A diagnosis or suspicion of immunodeficiency disorder (either in the participant or in a member of the immediate family) will also render the child ineligible for the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials